Clinical Trial Tracker

Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study

Cerebrolysin in Critically Ill Patients With Delirium

Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Study of Healthy Aging and Physical Function With Elamipretide

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

Semaglutide for Smoking Cessation in Patients With Diabetes

Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness

A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

BPC 157 for Acute Hamstring Muscle Strain Repair

Topical GHK-Cu Gel for Acute Skin Wound Healing

TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)

Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study

Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

Reproductive Hormones During Sustained Administration of Kisspeptin

Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Kisspeptin Administration Subcutaneously to Patients With IHH

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

SYNCHRONIZE-CVOT: Cardiovascular Outcomes With Survodutide

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

REDEFINE CVOT: CagriSema Cardiovascular Outcomes

EVOKE: Semaglutide in Early Alzheimer's Disease

SEER-2: RGN-259 for Neurotrophic Keratopathy

REDEFINE 1: CagriSema vs Semaglutide in Obesity

A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity

SYNCHRONIZE-1: Survodutide for Weight Management in Adults With Obesity

CERebrolysin In CADASIL

TRIUMPH-1: Obesity without T2D

TRIUMPH-3: Obesity with CVD

TRIUMPH-2: Obesity with T2D

A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector

SYNCHRONIZE-2: Survodutide for Weight Management in Adults With Obesity and Type 2 Diabetes

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

TRIUMPH-5: Head-to-head vs Tirzepatide

ACHIEVE: A Study of Survodutide in Adults With MASH and Fibrosis

A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity

A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

SURMOUNT-MMO

TRIUMPH-6: Long-term Maintenance (116 weeks)

A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

TRIUMPH-Outcomes: CV/Kidney Outcomes

REDEFINE 3: CagriSema vs Tirzepatide

Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion

Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1

The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)

Exploring Cerebrolysin in Late Thrombectomy for Stroke: Blood-brain Barrier Biomarkers and Imaging Insights

Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial

Tirzepatide in Idiopathic Intracranial Hypertension Trial

DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies

SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer (Phase 1)

Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction

A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight

A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease

AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)

Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation

Incretin Therapies in Obesity-related HFpEF

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Clinical Trial in Patients With Barth Syndrome- 4TAZPower

Metabolic Surgery for Atrial Fibrillation Elimination

Metabolic Surgery for Atrial Fibrillation Elimination

Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth

Promoting Healthy Children and Youth

Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity

Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes

TH9507 in Patients With HIV-Associated Lipodystrophy

Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke

Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease

Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Study of Thymosin Beta 4 in Patients With Pressure Ulcers

Thymosin Beta 4 in Venous Stasis Ulcers

Ipamorelin for Postoperative Ileus

Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men

Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke

Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of Intravenous (IV) Infusion of MTP-131 (Bendavia™) in Healthy Adults

The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke

Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.

Thymosin Beta 4 Dry Eye Controlled Adverse Environment

SMART: Somatotrophics, Memory, and Aging Research Trial

Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese

Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia

The Impact of Intravenous Bendavia™ on Endothelial Reactivity Dysfunction in Cigarette Smoking

Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder

Effects of Short-term Growth Hormone in HIV-infected Patients

Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye

A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)

Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days

Dose-Finding Study of Ipamorelin for Post-Surgical GI Recovery

Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy

KP-10 and Insulin Secretion in Men

Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke

Effects of Growth Hormone Releasing Hormone in HIV

Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.

Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in Men

Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

EMBRACE STEMI: Elamipretide in ST-Elevation Myocardial Infarction

A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration

A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function

Slow-release Tb4 Collagen and Chitosan Porous Sponge Scaffolds Skin Substitute Treatment is Difficult to Heal Wounds

Hair Repigmentation During Cerebrolysin Therapy

SUSTAIN-6: Cardiovascular Outcomes Trial

Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling

TAZPOWER-Barth: Elamipretide in Barth Syndrome

Neuropeptides in Human Reproduction

Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1

1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

Phase 1/2 Dose-Escalation Study in Primary Mitochondrial Myopathy

2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment

TAZPOWER: Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Myopathy

PROGRESS-HF: Elamipretide in Heart Failure With Reduced Ejection Fraction

Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction

Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2

Elamipretide in Leber's Hereditary Optic Neuropathy (LHON)

A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers

A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)

An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration

ReCLAIM: Elamipretide Topline in Dry AMD

Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage

Tesamorelin Effects on Liver Fat and Histology in HIV

The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment

Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke

A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers

the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome

Cerebrolysin and Neurodevelopment in Preterm Infants

Tachykinin and Kisspeptin Expression in Human Granulosa and Cumulus Cells

Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran

A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants

Elamipretide in Renal Artery Stenosis (EVREST)

Kisspeptin in the Evaluation of Delayed Puberty

Phase 2 Cagrilintide Monotherapy for Weight Management

Phase 1b Cagrilintide + Semaglutide Combination PK/PD

STEP 1: Weight Management in Obesity

SURPASS-1

Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder

Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3

Phase 1 First-in-Human Study of BI 456906

SURPASS-3

SURPASS-5

A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)

SURPASS-4

SURPASS-2

Phase 2 Study of BI 456906 in Type 2 Diabetes

Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia

Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction

Kisspeptin Administration in the Adult

Phase 2 CagriSema in Type 2 Diabetes

ReCLAIM-2: Elamipretide in Geographic Atrophy Secondary to Dry AMD

SURMOUNT-1

Phase 2 Obesity Trial

A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)

Phase 2 T2D Trial

A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test

SELECT: CV Outcomes in Obesity without Diabetes

A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants

SURMOUNT-2

SURMOUNT-3

SURMOUNT-4

A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)

Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction

A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants

Administration of Kisspeptin in Patients With Hyperprolactinemia

A Study of LY3437943 in Chinese Participants With Obesity Or Overweight

Phase 2 Study of BI 456906 in Adults With Obesity

A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons

Phase 2 Study of BI 456906 in NASH/MASH

A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906

FLOW: Kidney Outcomes in T2D with CKD

A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices

SURMOUNT-OSA

A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

Dampening the Reproductive Axis With Continuous Kisspeptin

Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants

FRDA Investigator Initiated Study (IIS) With Elamipretide

SUMMIT (HFpEF)

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese

A Study of LY3437943 in Healthy Participants With a High Body Mass Index

Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)

SURMOUNT-5

REDEFINE 2: CagriSema in Obesity with T2D

A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

A Study of LY3437943 in Participants With Impaired and Normal Liver Function

To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants

A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body

A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body

Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU

SURPASS-CVOT

A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight

A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders

Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body

A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

TRIUMPH-4: Obesity with Knee OA

Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Cerebrolysin and Recovery After Stroke (CARS)

Cerebrolysin and Recovery After Stroke 2 (CARS2)

Cerebrolysin Acute Stroke Treatment in Asia (CASTA)

Cerebrolysin in Vascular Dementia

Cerebrolysin in Moderate Alzheimer's Disease

E-CARS Extension Study

A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia

Swiss clinical studies in insomnia (1980s)

Russian clinical investigations (1980s-1990s)

Glutathione in Cystic Fibrosis

IV Glutathione in Parkinson's Disease

Liposomal Glutathione in HIV

LL-37 for Treatment of Venous Leg Ulcers

LL-37 in Melanoma

Omiganan for Rosacea

Thymosin Beta 4 Eye Drops for Dry Eye

SEER-1: RGN-259 for Neurotrophic Keratopathy

Tβ4 in Horse Tendon Injuries

SURPASS J-mono

SURPASS J-combo

China Phase 1 PK

A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds

A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa

Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448

Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting

The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery

A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism

Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery

Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1

SPIMM-301: Subcutaneous Elamipretide in Primary Mitochondrial Myopathy

Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)

IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE

Recall by Genotype: Neuropeptide Stimulation

Body Composition and Adipose Tissue in HIV

A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity

Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue

A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers

Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia

RGN-352 for Acute Myocardial Infarction

Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance

Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of PL 14736 in Healthy Male Subjects

Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy

Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-Arm

Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT

Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.

Effects of Cerebrolysin on Level of Consciousness and Brain Metabolism in Disorder of Consciousness After Stroke: Single Center Randomized Controlled Study

A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)

Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery

Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke

CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke

Multiple Phase I/II trials for IBD (PL-10, PLD-116)

Antimicrobial Peptide in Atopic Dermatitis

SEER-3: RGN-259 for Neurotrophic Keratopathy